IRCT2014041817325N1已完成2 期
Assessment of propranolol efficacy on pediatric hemangioma
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 1 day 至 14 years（—）
- 性别
- All
入选标准
- •Patients with hemangioma under 15 years old
- •Exclusion criteria: Patients with cardiovascular disease; patients with history of low blood sugar; patients use another drugs last 6 months.
排除标准
- 未提供
研究者
相似试验
尚未招募
2 期
Propranolol and hemodynamics and sedatioIRCT20210614051574N1Esfahan University of Medical Sciences72
Unknown
2 期
''Efficacy of Propranolol in the Treatment of Infantile Hemangioma"Infantile HemangiomaNCT04684667Assiut University100
招募中
3 期
Investigating the efficacy of oral propranolol in prevention of severe Retinopathy of PrematurityRetinopathy of prematurityIRCT20101018004961N12Kermanshah University of Medical Sciences50
进行中（未招募）
不适用
PROPRANOLOL IN BURNT ADULT PATIENTSBURNT-INDUCED SINUSAL TACHYCARDIAEUCTR2014-001380-13-ESAbelardo Garcia De Lorenzo / Teresa Nuñez-Villaveiran
进行中（未招募）
不适用
The use of systemic propranolol in congenital hemangiomas - CDO0901congenital hemangiomasMedDRA version: 12.1Level: LLTClassification code 10018818Term: Haemangioma congenitalEUCTR2009-014571-49-ITAZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI